mastodon.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
The original server operated by the Mastodon gGmbH non-profit

Administered by:

Server stats:

351K
active users

#drugmakers

0 posts0 participants0 posts today
LilMikeSF<p><a href="https://c.im/tags/BioTech" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>BioTech</span></a> industry responsible for more than 115,000 <a href="https://c.im/tags/Massachusetts" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Massachusetts</span></a> jobs is struggling amidst a slump. The <a href="https://c.im/tags/Boston" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Boston</span></a> area is a bio research hub with 1,000 <a href="https://c.im/tags/drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugmakers</span></a>, but part of problem for the NE Democrat political and <a href="https://c.im/tags/science" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>science</span></a> edu stronghold is higher costs of operations than elsewhere.</p><p>For example, In burgeoning <a href="https://c.im/tags/RaleighDurham" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RaleighDurham</span></a> NC Triangle drugmakers face far lower taxes and can pay lower wages. </p><p><a href="https://www.statnews.com/2025/03/13/biotech-boston-area-slump/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">statnews.com/2025/03/13/biotec</span><span class="invisible">h-boston-area-slump/</span></a></p>
Georgiann Baldino<p>Reuters "<a href="https://mastodon.world/tags/Drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Drugmakers</span></a> to raise US prices on over 250 medicines starting Jan. 1...A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022." </p><p><a href="https://finance.yahoo.com/news/drugmakers-raise-us-prices-over-120529214.html" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">finance.yahoo.com/news/drugmak</span><span class="invisible">ers-raise-us-prices-over-120529214.html</span></a><br><a href="https://mastodon.world/tags/NewYear" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NewYear</span></a></p>
Catherine Collingwood Estes<p>"The new rules instruct <a href="https://mstdn.social/tags/drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugmakers</span></a> to use simple, consumer-friendly language when describing their <a href="https://mstdn.social/tags/drugs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugs</span></a>, without medical jargon, distracting visuals or audio effects." <a href="https://mstdn.social/tags/Prescriptions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Prescriptions</span></a> <a href="https://mstdn.social/tags/Advertising" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Advertising</span></a> <a href="https://buff.ly/48SfY7q" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/48SfY7q</span><span class="invisible"></span></a></p>
LilMikeSF<p>By 2019 popular non prescription <a href="https://c.im/tags/heartburn" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>heartburn</span></a> <a href="https://c.im/tags/medication" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>medication</span></a> <a href="https://c.im/tags/Zantac" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Zantac</span></a> was recalled from retail after it was found to contain an <a href="https://c.im/tags/antihistamine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>antihistamine</span></a> that blocks the release of stomach acid called N-nitrosodimethylamine (<a href="https://c.im/tags/NDMA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NDMA</span></a>) that is linked to causing <a href="https://c.im/tags/cancer" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>cancer</span></a>. </p><p><a href="https://c.im/tags/Drug" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Drug</span></a> Mfgr <a href="https://c.im/tags/GSK" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GSK</span></a> has reached $2.2bn <a href="https://c.im/tags/legalsettlement" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>legalsettlement</span></a> in US that is supposed to cover 93% of user cases brought thus far. </p><p>Previously <a href="https://c.im/tags/GlaxoSmithKline" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GlaxoSmithKline</span></a> had paid $70m to settle with the lab that discovered the issue, and other big <a href="https://c.im/tags/drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugmakers</span></a> that also marketed the <a href="https://c.im/tags/OTC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OTC</span></a> drug, including <a href="https://c.im/tags/Pfizer" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Pfizer</span></a> and <a href="https://c.im/tags/Sanofi" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Sanofi</span></a>, have already reached sizable settlements.</p><p><a href="https://on.ft.com/4eBVq5g" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">on.ft.com/4eBVq5g</span><span class="invisible"></span></a> <a href="https://c.im/tags/FinancialTimes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>FinancialTimes</span></a> <a href="https://c.im/tags/GiftLink" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GiftLink</span></a> <a href="https://c.im/tags/Legal" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Legal</span></a> <a href="https://c.im/tags/ProductLiability" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ProductLiability</span></a></p>
Nonilex<p><a href="https://masto.ai/tags/GiftArticle" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GiftArticle</span></a> on <a href="https://masto.ai/tags/SCOTUS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SCOTUS</span></a>’ ruling on <a href="https://masto.ai/tags/PurduePharma" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PurduePharma</span></a> <a href="https://masto.ai/tags/opioid" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>opioid</span></a> case</p><p>The <a href="https://masto.ai/tags/SupremeCourt" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SupremeCourt</span></a> blocked a controversial proposed Purdue <a href="https://masto.ai/tags/Pharma" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Pharma</span></a> bankruptcy plan that would have provided billions to help address the nation’s <a href="https://masto.ai/tags/OpioidCrisis" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpioidCrisis</span></a> in exchange for protecting the <a href="https://masto.ai/tags/Sackler" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Sackler</span></a> family from future lawsuits.<br>
The closely watched fight involving the maker of <a href="https://masto.ai/tags/OxyContin" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OxyContin</span></a> is part of a national reckoning over the role of <a href="https://masto.ai/tags/drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugmakers</span></a> &amp; others in the <a href="https://masto.ai/tags/PublicHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PublicHealth</span></a> opioid <a href="https://masto.ai/tags/addiction" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>addiction</span></a> crisis.</p><p><a href="https://masto.ai/tags/law" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>law</span></a> <br><a href="https://wapo.st/3VLn8UX" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">wapo.st/3VLn8UX</span><span class="invisible"></span></a></p>
Global News<p>Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition<br>The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.<br><a href="https://mastodon.hongkongers.net/tags/globalnews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>globalnews</span></a> <a href="https://mastodon.hongkongers.net/tags/Health" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Health</span></a> <a href="https://mastodon.hongkongers.net/tags/USNews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>USNews</span></a> <a href="https://mastodon.hongkongers.net/tags/Drugpatents" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Drugpatents</span></a> <a href="https://mastodon.hongkongers.net/tags/drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugmakers</span></a> <br><a href="https://globalnews.ca/news/10460967/us-drug-patents-challenged-ozempic/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">globalnews.ca/news/10460967/us</span><span class="invisible">-drug-patents-challenged-ozempic/</span></a></p>
Global News National<p>Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition<br>The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.<br><a href="https://mastodon.hongkongers.net/tags/globalnews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>globalnews</span></a> <a href="https://mastodon.hongkongers.net/tags/Health" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Health</span></a> <a href="https://mastodon.hongkongers.net/tags/USNews" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>USNews</span></a> <a href="https://mastodon.hongkongers.net/tags/Drugpatents" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Drugpatents</span></a> <a href="https://mastodon.hongkongers.net/tags/drugmakers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugmakers</span></a> <br><a href="https://globalnews.ca/news/10460967/us-drug-patents-challenged-ozempic/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">globalnews.ca/news/10460967/us</span><span class="invisible">-drug-patents-challenged-ozempic/</span></a></p>